Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.495 EUR | -5.98% | -11.56% | -60.08% |
May. 28 | Evotec Extends Drug Discovery Collaboration With CHDI Foundation for Huntington's Disease | MT |
May. 28 | Evotec, CHDI Foundation Extend 20-year Partnership for Huntington's Disease Treatments | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.08% | 1.74B | |
+48.67% | 58.71B | |
-2.76% | 41.31B | |
+36.42% | 39.2B | |
-11.22% | 27.4B | |
+9.25% | 26.55B | |
-23.10% | 18.98B | |
+1.88% | 12.51B | |
+26.43% | 12.08B | |
+21.74% | 11.94B |
- Stock Market
- Equities
- EVT Stock
- News Evotec SE
- Evotec, Novo Nordisk Partner for Translational Drug Discovery Accelerator